Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases

Lignende værker

• Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis
  af: Carli, Edoardo, et al.
  Udgivet: (2020)
• On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
  af: Caviglia, Gian Paolo, et al.
  Udgivet: (2020)
• Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report
  af: Caviglia, Gian Paolo, et al.
  Udgivet: (2020)
• Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary Report
  af: Gian Paolo Caviglia, et al.
  Udgivet: (2020-07-01)
• Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity (“lymphocytic enterocolitis”)?
  af: Bonagura, Gabriele Antonio, et al.
  Udgivet: (2016)